Schaub, Friederike
Hoerster, Robert
Schiller, Petra
Felsch, Moritz
Kraus, Daria
Zarrouk, Marouan
Kirchhof, Bernd
Fauser, Sascha
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (FA 441/4-1, FA 441/4-1)
Article History
Received: 24 February 2017
Accepted: 25 June 2018
First Online: 16 July 2018
Ethics approval and consent to participate
: Before the start of the clinical trial, all necessary documentation has been submitted to the competent supreme federal authority for approval (Federal Institute for Drugs and Medical Products, Bundesinstitut für Arzneimittel und Medizinprodukte [BfArM]) and the local IRBs of all attending centers. Favorable opinions have been received (ethics committee of the medical faculty at the University of Cologne; IRB no. 16–192). Written informed consent of participants is obtained.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.